Thymosin Alpha-1
A$319
Thymosin Alpha-1
A naturally occurring peptide that plays a crucial role in immune system modulation. Used clinically in many countries for immune support and viral infections.
Commonly considered for
Immune enhancement
T-cell activation
Viral defence
Vaccine response
Chronic infection support
How it works
Enhances T-cell function, stimulates dendritic cell maturation, and modulates cytokine production. Supports both innate and adaptive immune responses.
Typical Use
Administered via subcutaneous injection. Often used during illness or as preventative immune support.
Often stacked with
Storage
Store unopened pens refrigerated at 2–8°C. Opened/activated pens should be used within 28 days when kept refrigerated. Do not freeze. Keep away from direct sunlight.
Practitioner Review
This compound is supplied exclusively following a Zenith assessment, bloodwork panel, and practitioner sign-off. Every supply includes a protocol card and dosing guide.
Research context: FDA Orphan Drug status. Approved in over 35 countries for hepatitis B/C and as immune adjuvant.
Frequently asked
Administered via subcutaneous injection. Often used during illness or as preventative immune support.
Enhances T-cell function, stimulates dendritic cell maturation, and modulates cytokine production. Supports both innate and adaptive immune responses.
Thymosin Alpha-1 is commonly used alongside BPC-157, NAD+, Glutathione.
All Zenith compounds are supplied exclusively following assessment, bloodwork, and practitioner review.
Regulatory & safety information
Thymosin Alpha-1 is supplied subject to suitability assessment and applicable UAE regulatory requirements. Information provided is general and is not a substitute for professional medical advice, diagnosis or treatment.
Always consult a qualified healthcare professional before starting, changing or stopping any product, particularly if you are pregnant, breastfeeding, under 18, or managing a medical condition.
Why treatment isn't self-selected
Treatment decisions need context.
Selecting a treatment option is the starting point. What's clinically appropriate for you is determined by three things together.
Your bloodwork
Relevant biomarkers help identify which treatment options may be appropriate — and which should be avoided.
Your health history
Existing conditions, medications and goals are considered alongside your results, not in isolation.
Practitioner review
A licensed practitioner reviews every request before anything is approved, dosed or supplied.
Before you choose
Your bloodwork can change the conversation.
Recent bloodwork gives your practitioner more to work with — helping identify what may be appropriate, what should be avoided, and where a different option might be better suited to your results.
Already uploaded results? Your practitioner reviews them alongside any treatment request — no need to repeat information.
Optional at this stage. Required before final approval.
Ready to move forward?
Three ways to continue.
Upload your bloodwork
Already have recent results? Upload them so your practitioner can review your treatment request in context.
Purchase a blood test
No recent results? Order an at-home Zenith blood test to establish your baseline before choosing treatment.
Start your assessment
Begin the health assessment now — you can add bloodwork and treatment selections at any stage.
Purchase
Thymosin Alpha-1
Supplied following assessment, bloodwork and practitioner review.
Price
A$319
Ready to start?
Complete an assessment and get access to Thymosin Alpha-1 through a tailored protocol.